ASH-EHA Translational Research Training in Hematology Grant

The ASH-EHA Translational Research Training in Hematology (TRTH) program is a collaborative initiative by the American Society of Hematology and the European Hematology Association aimed at fostering early-stage researchers. This prestigious year-long training offers mentorship and covers vital topics such as biostatistics, genetics, and clinical study design. Selected participants, including junior faculty and postdoctoral fellows, gain essential skills to advance their careers in blood-related translational research.

A joint effort of the American Society of Hematology (ASH) and the European Hematology Association (EHA), Translational Research Training in Hematology (TRTH) is a unique, year-long training and mentoring program focused on helping early stage researchers, including senior postdoctoral fellows and junior faculty, gain the tools necessary to build successful careers in blood-related translational research.
Each year, 24 early-career scientists (12 ASH Members and 12 EHA Members) are selected to participate in the prestigious and rigorous training program led by faculty who are international leaders in hematology. Topics covered include biostatistics and biomarkers, genetics and molecular biology, ethics, and phase I clinical study design.

Eligibility

Applicants must be a trainee or junior faculty and hold an MD and/or PhD or biomedical PhD or pharmacy PharmD degree (or equivalents) in basic and translation research in classical or malignant hematology.MD applicants must be within twelve years of post-graduation at the time of the deadline for full application. PhD applicants must have less than eight years of post-doc experience after graduation at the time of the deadline for full application. Applicants holding both an MD and a PhD must be within 12 years of MD-graduation. Exceptions may be made for interruptions in an applicant's academic pursuits. Applicants must be actively employed in a hematology or hematology-related research environment.Proficiency in English is required.At the time of application and for the duration of the TRTH program, eligible applicants must be in classical or malignant hematology-related fellowship training.Fellowship training is defined as any sub-specialty training in hematology irrespective of whether this training is concurrent with another training program.Applicants from the same institution are eligible to apply. However, no more than ONE participant working in the same lab/research unit will be selected and no more than TWO from the same institution.Applicants with the same mentor are eligible to apply. However, no more than ONE participant from a specific mentor will be selected.Research projects must be hypothesis-driven and directly connected to some aspects of human biology. Projects may encompass any form of cellular, molecular, structural, biochemical, genetic, or other appropriate experimental approach using human biological material or human subjects with the aim of reaching novel insights into human biology. Pilot and early phase clinical studies translating the laboratory discoveries "to the bedside" may be included in the proposal, however, pure clinical trial projects with laboratory correlatives will not be considered.
You must be a member of this organization to apply for this award - become a member. Both the applicant and the applicant's mentor should be either an EHA member, or an ASH member at the time of LOI submission and throughout the term of the award program.

Ineligibility

Applicants with certain professional credentials will not be considered, such as principal investigators, applicants holding more senior faculty positions, including being an established research group leader, and applicants who have obtained funding indicative of independent research status, tenure-track faculty with more than one year experience at this faculty level.TRTH is not designed for those with less than 2 years of postdoctoral research experience.Applicants working primarily on clinical research projects will not be considered.